Cancer patients’ thymic health is linked to their response to immunotherapy 

In cancer patients, the health of the thymus—a key part of the body’s immune system—is associated with the outcomes these patients experience after immune checkpoint inhibitor treatment, according to an international study reported at ESMO 2025.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup